TELA Bio, Inc.
NASDAQ: TELA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Antony Koblish
- Employees
- 217
- Headquarters
- Malvern, United States
- IPO year
- 2019
- Market cap
- $33.6M
- Website
- https://www.telabio.com
Loading TELA…
Loading profile data…Frequently asked questions about TELA
What does TELA Bio, Inc. (TELA) do?
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal w...
Where does TELA trade?
TELA Bio, Inc. (TELA) trades on the NASDAQ.
What sector is TELA in?
TELA Bio, Inc. (TELA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of TELA Bio, Inc.?
Antony Koblish is the chief executive officer of TELA Bio, Inc. (TELA).
Where is TELA Bio, Inc. headquartered?
TELA Bio, Inc. is headquartered in United States.
Does TELA pay a dividend?
TELA Bio, Inc. (TELA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TELA go public?
TELA Bio, Inc. (TELA) completed its initial public offering in 2019.